Although CytoDyn has chosen to withdraw the resubm
Post# of 148273
(Total Views: 535)
Posted On: 10/28/2022 10:40:17 PM
Re: chazzledazzle #129747
Although CytoDyn has chosen to withdraw the resubmission of the BLA for MDA HIV, I do not believe, that this trial was done completely in vain. I do believe that the aggregated data, may be re-compiled and combined with other HIV trials from the past and in the future, to "qualify" the drug to be used as a mono-therapy for a combination indication such as NASH + HIV.
(4)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼